SCHEMBL2652798

SCHEMBL2652798

CNS(=O)(=O)c1ccc(C2(C(=O)O)CC2)c(C2CCCCC2)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ LMNA P02545 2/20 0.42
▸ SLC6A2 P23975 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ PTGS2 P35354 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ POLB P06746 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CYP3A4 P08684 1/20 0.36
▸ PDE7A Q13946 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2653280 0.86 PTGS2 (0.44) ALDH1A1KMT2ALMNASLC6A2SLC6A4
SCHEMBL2652827 0.85 PTGS2 (0.42) ALDH1A1KMT2ALMNASLC6A2SLC6A4
SCHEMBL2652919 0.81 CNR2 (0.36) ALDH1A1KMT2ALMNASMN1; SMN2POLB
SCHEMBL2653267 0.77 CA2 (0.38) POLBCYP3A4
SCHEMBL2654132 0.76 PTGS2 (0.41) ALDH1A1KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL2653490 0.76 CYP3A4 (0.41) KMT2AMEN1CYP3A4KDM4EMAPT
SCHEMBL2654413 0.76 PTGDR2 (0.51) KMT2ASMN1; SMN2MEN1POLBCYP3A4
SCHEMBL2653153 0.76 ALDH1A1 (0.54) ALDH1A1KMT2ALMNASMN1; SMN2MEN1
SCHEMBL2655512 0.75 PTGDR2 (0.55) KMT2AMEN1CYP3A4MAPT
SCHEMBL2653863 0.75 RAB9A (0.48) ALDH1A1KMT2ALMNASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1585739-A1 SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS ELI LILLY AND COMPANY (US) 2005-10-19 — — EP disclosed
WO-2004063179-A1 SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS ELI LILLY AND COMPANY (US) 2004-07-29 — — WO disclosed
Send feedback